REGULATORY AFFAIRS AND QUALITY ASSURANCE
Cutanea Life Sciences
United States of America
Jennifer W. Phillips is a regulatory affairs professional having more than 20 years of experience in the pharmaceutical industry with 10 years in the dermatological drug development. Dr. Phillips has extensive background in development of regulatory strategy, to support new product registration and commercialization as well as review of promotional advertising materials for prescription drugs and medical devices. Dr. Phillips rejoined Cutanea Life Sciences as Vice President, Regulatory Affairs and Quality Assurance in April of 2012. She previously served as Sr. Director, Regulatory Affairs for CLS between 2005 and 2008. Prior to Cutanea, Dr. Phillips was Sr. Director, Regulatory Affairs for Mutual Pharmaceuticals Co. where she was primarily responsible for 505B2 development. In addition, Dr. Phillips also headed the Regulatory Affairs group for Dermik Laboratories, a division of Sanofi-Aventis. Dr. Phillips received her Doctor of Pharmacy from the University of North Carolina, Chapel Hill, NC. She supplemented her degree by completing a Clinical Research/Drug Development Fellowship from the University of North Carolina, Chapel Hill, NC. She received a Bachelor of Science-Pharmacy from the University of the Sciences, Philadelphia, PA. Dr. Phillips is also a graduate of the International Business leadership Program, University of Nijenrode, The Netherlands.
Pharmaceutical, Dermatological Drug Development